Literature DB >> 17584896

Single median maxillary central incisor: new data and mutation review.

Kênia B El-Jaick1, Renata F Fonseca, Miguel A Moreira, Márcia G Ribeiro, Ana M Bolognese, Sânia O Dias, Eliane T Pereira, Eduardo E Castilla, Iêda M Orioli.   

Abstract

BACKGROUND: Single median maxillary central incisor (SMMCI) is a rare anomaly that may occur alone or associated with other conditions, frequently as part of the holoprosencephaly (HPE) spectrum. However, it has been suggested that SMMCI alone, or associated with some midline defects, may be considered a different entity from HPE (OMIM: 147250). Families with SMMCI, without HPE cases, are difficult to counsel for the risk of HPE in future generations because the same midline defects described as part of the "SMMCI syndrome" can also be part of the HPE spectrum.
METHODS: We screened five cases of SMMCI for mutations in three HPE genes, SHH, TGIF, and SIX3.
RESULTS: A missense mutation c.686C>T was found in the gene SIX3 of one patient, which did not differ from the accepted 20% of known HPE gene mutations among all HPE cases. Our results and an extensive literature review of gene mutations in patients with SMMCI showed that 27/28 of them were in HPE genes: SHH (n = 21), SIX3 (n = 3), TGIF (n = 1), GLI2 (n = 1), and PTCH (n = 1), and only one in the SALL4 gene.
CONCLUSIONS: The clinical findings in patients with SMMCI without HPE in families with mutations in HPE genes cannot be distinguished from the findings reported in the SMMCI syndrome. Therefore, persons with SMMCI and their relatives should be carefully investigated for related midline disorders, especially of the HPE spectrum, and all known HPE genes screened. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584896     DOI: 10.1002/bdra.20380

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  12 in total

1.  The unfolding clinical spectrum of holoprosencephaly due to mutations in SHH, ZIC2, SIX3 and TGIF genes.

Authors:  Aimée D C Paulussen; Constance T Schrander-Stumpel; Demis C J Tserpelis; Matteus K M Spee; Alexander P A Stegmann; Grazia M Mancini; Alice S Brooks; Margriet Collée; Anneke Maat-Kievit; Marleen E H Simon; Yolande van Bever; Irene Stolte-Dijkstra; Wilhelmina S Kerstjens-Frederikse; Johanna C Herkert; Anthonie J van Essen; Klaske D Lichtenbelt; Arie van Haeringen; Mei L Kwee; Augusta M A Lachmeijer; Gita M B Tan-Sindhunata; Merel C van Maarle; Yvonne H J M Arens; Eric E J G L Smeets; Christine E de Die-Smulders; John J M Engelen; Hubertus J Smeets; Jos Herbergs
Journal:  Eur J Hum Genet       Date:  2010-06-09       Impact factor: 4.246

2.  Utilizing prospective sequence analysis of SHH, ZIC2, SIX3 and TGIF in holoprosencephaly probands to describe the parameters limiting the observed frequency of mutant gene×gene interactions.

Authors:  Erich Roessler; Jorge I Vélez; Nan Zhou; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2012-01-12       Impact factor: 4.797

Review 3.  Developmental disorders of the dentition: an update.

Authors:  Ophir D Klein; Snehlata Oberoi; Ann Huysseune; Maria Hovorakova; Miroslav Peterka; Renata Peterkova
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-10-04       Impact factor: 3.908

4.  Septopreoptic holoprosencephaly: a mild subtype associated with midline craniofacial anomalies.

Authors:  J S Hahn; P D Barnes; N J Clegg; E E Stashinko
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-20       Impact factor: 3.825

5.  The mutational spectrum of holoprosencephaly-associated changes within the SHH gene in humans predicts loss-of-function through either key structural alterations of the ligand or its altered synthesis.

Authors:  Erich Roessler; Kenia B El-Jaick; Christèle Dubourg; Jorge I Vélez; Benjamin D Solomon; Daniel E Pineda-Alvarez; Felicitas Lacbawan; Nan Zhou; Maia Ouspenskaia; Aimée Paulussen; Hubert J Smeets; Ute Hehr; Claude Bendavid; Sherri Bale; Sylvie Odent; Véronique David; Maximilian Muenke
Journal:  Hum Mutat       Date:  2009-10       Impact factor: 4.878

6.  A novel SIX3 mutation segregates with holoprosencephaly in a large family.

Authors:  Benjamin D Solomon; Felicitas Lacbawan; Mahim Jain; Sabina Domené; Erich Roessler; Cynthia Moore; William B Dobyns; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2009-05       Impact factor: 2.802

7.  Mutations in the human SIX3 gene in holoprosencephaly are loss of function.

Authors:  Sabina Domené; Erich Roessler; Kenia B El-Jaick; Mirit Snir; Jamie L Brown; Jorge I Vélez; Sherri Bale; Felicitas Lacbawan; Maximilian Muenke; Benjamin Feldman
Journal:  Hum Mol Genet       Date:  2008-09-12       Impact factor: 6.150

8.  Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function.

Authors:  F Lacbawan; B D Solomon; E Roessler; K El-Jaick; S Domené; J I Vélez; N Zhou; D Hadley; J Z Balog; R Long; A Fryer; W Smith; S Omar; S D McLean; K Clarkson; A Lichty; N J Clegg; M R Delgado; E Levey; E Stashinko; L Potocki; M I Vanallen; J Clayton-Smith; D Donnai; D W Bianchi; P B Juliusson; P R Njølstad; H G Brunner; J C Carey; U Hehr; J Müsebeck; P F Wieacker; A Postra; R C M Hennekam; M-J H van den Boogaard; A van Haeringen; A Paulussen; J Herbergs; C T R M Schrander-Stumpel; A R Janecke; D Chitayat; J Hahn; D M McDonald-McGinn; E H Zackai; W B Dobyns; M Muenke
Journal:  J Med Genet       Date:  2009-04-02       Impact factor: 6.318

Review 9.  The molecular genetics of holoprosencephaly.

Authors:  Erich Roessler; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

10.  Molecular analysis of holoprosencephaly in South America.

Authors:  Clarice Pagani Savastano; Kênia Balbi El-Jaick; Marcelo Aguiar Costa-Lima; Cristina Maria Batista Abath; Sebastiano Bianca; Denise Pontes Cavalcanti; Têmis Maria Félix; Gioacchino Scarano; Juan Clinton Llerena; Fernando Regla Vargas; Miguel Ângelo Martins Moreira; Hector N Seuánez; Eduardo Enrique Castilla; Iêda Maria Orioli
Journal:  Genet Mol Biol       Date:  2014-03       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.